Cargando…

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia

BACKGROUND: Oral glucocorticoids are widely used to reduce pruritus and dermatitis associated with allergic dermatitis. Data suggest that oclacitinib, a Janus kinase inhibitor, is a safe and effective alternative. HYPOTHESIS/OBJECTIVES: To evaluate the efficacy and safety of oclacitinib compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadeyne, Caroline, Little, Peter, King, Vickie L, Edwards, Nigel, Davis, Kylie, Stegemann, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Scientific Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282467/ https://www.ncbi.nlm.nih.gov/pubmed/25109820 http://dx.doi.org/10.1111/vde.12166

Ejemplares similares

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
por: Cosgrove, Sallie B, et al.
Publicado: (2013)

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
por: Gonzales, A J, et al.
Publicado: (2014)

A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery
por: Motz, Alyssa K., et al.
Publicado: (2023)

Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib
por: Mwacalimba, Kennedy, et al.
Publicado: (2023)

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis
por: Van Brussel, Leen, et al.
Publicado: (2021)

The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
por: Rynhoud, Hester, et al.
Publicado: (2021)

The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study
por: Rynhoud, Hester, et al.
Publicado: (2022)

An open, self-controlled study on the efficacy of topical indoxacarb for eliminating fleas and clinical signs of flea-allergy dermatitis in client-owned dogs in Queensland, Australia
por: Fisara, Petr, et al.
Publicado: (2014)

Complete remission of two canine cases with precursor-targeted immune-mediated anemia after combination therapy with prednisolone, cyclosporine, and oclacitinib
por: Yuki, Masashi, et al.
Publicado: (2023)

Evaluation of topical oclacitinib and nail trimming as a treatment for murine ulcerative dermatitis in laboratory mice
por: Davison, Steven E., et al.
Publicado: (2022)

Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis
por: Dip, Ramiro, et al.
Publicado: (2013)

Topical royal jelly alleviates symptoms of pruritus in a murine model of allergic contact dermatitis
por: Yamaura, Katsunori, et al.
Publicado: (2013)

Argas reflexus dermatitis and nocturnal pruritus
por: Alipour Tehrany, Yassaman, et al.
Publicado: (2018)

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
por: Ashton, Laura V, et al.
Publicado: (2020)

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis
por: Loewinger, Melissa, et al.
Publicado: (2022)

Prednisolone prescribing practices for dogs in Australia
por: Purcell, Bonnie, et al.
Publicado: (2023)

A Nonsteroidal Novel Formulation Targeting Inflammatory and Pruritus-Related Mediators Modulates Experimental Allergic Contact Dermatitis
por: Gordon, William C., et al.
Publicado: (2018)

A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats
por: Lopes, Natália Lôres, et al.
Publicado: (2019)

Anthocyanins from bilberry (Vaccinium myrtillus L.) alleviate pruritus in a mouse model of chronic allergic contact dermatitis
por: Yamaura, Katsunori, et al.
Publicado: (2011)

Usefulness of a topical combination of dinotefuran and pyriproxyfen for long-term control of clinical signs of allergic dermatitis in privately-owned cats in Ile-de-France region
por: Crosaz, Odile, et al.
Publicado: (2017)

The Atomizer Sign: A Diagnostic Clue to Fragrance Allergic Contact Dermatitis
por: Rozas-Muñoz, Eduardo, et al.
Publicado: (2021)

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma
por: Ashton, Laura V., et al.
Publicado: (2023)

Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks
por: Panteri, Alessandro, et al.
Publicado: (2015)

Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
por: Harvey, Richard G., et al.
Publicado: (2022)

Neuroimmunological Mechanism of Pruritus in Atopic Dermatitis Focused on the Role of Serotonin
por: Kim, Kwangmi
Publicado: (2012)

The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus
por: Rerknimitr, Pawinee, et al.
Publicado: (2017)

Pruritus bei atopischer Dermatitis – vergleichende Bewertung neuer Therapieansätze
por: Müller, Svenja, et al.
Publicado: (2022)

The File Sync Algorithm of the ownCloud Desktop Clients
por: Mr. FREITAG, Klaas
Publicado: (2014)

Vaccine‐Associated Leptospira Antibodies in Client‐Owned Dogs
por: Martin, L.E.R., et al.
Publicado: (2014)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
por: Barrett, Laura E., et al.
Publicado: (2019)

Inherited Sensory and Autonomic Neuropathy in a Border Collie, Interest of Oclacitinib for the Control of Self-Mutilation
por: Leonard, Caroline, et al.
Publicado: (2022)

Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus
por: Teresiak-Mikołajczak, Ewa, et al.
Publicado: (2013)

Pruritus ani and perianal eczema as a manifestation of systemic contact dermatitis
por: Hadasik, Karolina, et al.
Publicado: (2017)

Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
por: Scuron, Monika D., et al.
Publicado: (2021)

Transcutaneous Slowly Depolarizing Currents Elicit Pruritus in Patients with Atopic Dermatitis
por: RUKWIED, Roman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2jvqhtm49304a3mhca2u5qlp3u